Edinburgh International Science Festival: The other side of sex

Vildagliptin (Galvus®) approved for use as monotherapy in the EU (NeLM News Service, 7 February 2012)

08 Feb 2012

Reports suggest that the European Commission has approved the use of vildagliptin (Galvus) as a monotherapy where patients with type 2 diabetes are unable to control their blood sugar with diet and exercise alone and cannot take metformin due to intolerance or contraindications.

Full article

Vildagliptin (Galvus®) approved for use as monotherapy in the EU (NeLM News Service, 7 February 2012)

Related Topics

Share this story

Top stories

Most read